DrugPatentWatch Database Preview

FRAGMIN Drug Profile

« Back to Dashboard

When do Fragmin patents expire, and what generic alternatives are available?

Fragmin is a drug marketed by Pfizer Inc and is included in one NDA.

The generic ingredient in FRAGMIN is dalteparin sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dalteparin sodium profile page.

Summary for FRAGMIN

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Clinical Trials:	33
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for FRAGMIN
DailyMed Link:	FRAGMIN at DailyMed

Pharmacology for FRAGMIN

Drug Class

Anti-coagulant Low Molecular Weight Heparin

Medical Subject Heading (MeSH) Categories for FRAGMIN

Anticoagulants

Fibrinolytic Agents

US Patents and Regulatory Information for FRAGMIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;INJECTION	020287-008	Apr 4, 2002		DISCN	No	No
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-009	May 1, 2007		RX	Yes	No
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-005	Apr 4, 2002		RX	Yes	No
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-010	May 1, 2007		RX	Yes	No
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-001	Dec 22, 1994		RX	Yes	No
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-003	Mar 18, 1996		RX	Yes	No

Expired US Patents for FRAGMIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-001	Dec 22, 1994
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-004	Jan 30, 1998
Pfizer Inc	FRAGMIN	dalteparin sodium	INJECTABLE;SUBCUTANEOUS	020287-003	Mar 18, 1996